NEW ORLEANS – In a significant transition for the field of reconstructive medicine, Babak J. Mehrara, MD, has officially assumed the presidency of The Plastic Surgery Foundation (The PSF). The appointment was formalized on October 12, 2025, during Plastic Surgery The Meeting, the American Society of Plastic Surgeons’ (ASPS) premier annual scientific conference. As he takes the helm of the organization—which serves as the research and philanthropic engine of the ASPS—Dr. Mehrara prepares to navigate a transformative year for surgical innovation, with his term set to conclude on October 18, 2026.
Main Facts: A Leader at the Intersection of Science and Surgery
The PSF functions as the charitable and research-focused arm of the American Society of Plastic Surgeons. Its primary mandate is to foster the advancement of plastic surgery through rigorous research, global education, and the support of emerging surgical talent. Dr. Mehrara’s selection to lead this organization is widely seen as a strategic move to bridge the gap between bench-side laboratory research and bedside clinical application.
Dr. Mehrara currently serves as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK) in New York City. He also holds the prestigious Peter G. Cordeiro Endowed Chair in the Department of Surgery. His clinical focus, which centers on complex oncologic reconstruction, aligns perfectly with the foundation’s mission to improve patient outcomes through high-impact, evidence-based practices.
Chronology: The Path to the Presidency
The trajectory of Dr. Mehrara’s career is marked by a consistent dedication to the intersection of academic research and patient care. His ascent to the presidency of The PSF follows decades of contributions to the medical community:
- Early Academic Foundation: Dr. Mehrara established himself as a prominent voice in surgical research early in his career, eventually securing a joint appointment as a Professor of Surgery at Weill Cornell Medical College.
- Scientific Leadership at MSK: At Memorial Sloan Kettering, he took the helm of the Lymphatic Biology Laboratory. Under his guidance, the laboratory secured significant funding from the National Institutes of Health (NIH), cementing its status as a premier center for lymphatic research.
- The 2025 Transition: Following years of active service within the ASPS and The PSF committees, Dr. Mehrara was formally named President-elect, leading to his installation on October 12, 2025, in New Orleans.
- The 2025–2026 Term: Over the next 12 months, Dr. Mehrara will lead the foundation’s strategic planning, with his term scheduled to end at the 2026 annual meeting.
Supporting Data: An Unmatched Academic Record
Dr. Mehrara’s credibility as a leader is rooted in his prolific output and his clinical expertise. His influence is not merely confined to the operating room; it is documented in over 400 peer-reviewed publications. This body of work has fundamentally altered the landscape of how surgeons approach cancer-related lymphedema—a chronic condition that affects millions of cancer survivors worldwide.
The Impact of the Lymphatic Biology Laboratory
The research directed by Dr. Mehrara at MSK has been pivotal in moving the needle on lymphatic disease management. By leveraging NIH grants, his laboratory has successfully translated molecular findings into clinical breakthroughs. This focus on "translational medicine"—the process of ensuring that scientific discoveries are quickly and safely turned into new treatments—will likely serve as the blueprint for his presidential tenure at The PSF.
Clinical Expertise
As a surgeon-scientist, Dr. Mehrara specializes in the reconstruction of patients who have undergone extensive cancer surgeries. His approach is defined by the integration of both surgical and nonsurgical modalities, ensuring that patients not only survive their cancer but recover their quality of life through advanced reconstructive techniques.
Official Responses and Strategic Vision
During his inaugural address, Dr. Mehrara articulated a clear vision for the foundation. He emphasized the necessity of nurturing the next generation of surgeons, particularly those who demonstrate a penchant for inquiry.
"It’s an honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators. Throughout my presidency, I will champion new ways to strengthen and expand The Foundation’s mission of research and education."
Dr. Mehrara’s leadership style is characterized by collaboration. He has frequently emphasized that the most profound breakthroughs occur when surgeons, biologists, and engineers work in concert. By fostering partnerships between academic institutions, private industry, and international surgical bodies, he aims to scale the impact of The PSF’s current initiatives.
Implications: The Future of Plastic Surgery Research
The election of Dr. Mehrara signals a shift toward a more data-driven, research-heavy era for the American Society of Plastic Surgeons. The implications for the field are significant and multi-faceted.
1. The Expansion of Evidence-Based Care
Under Dr. Mehrara’s leadership, The PSF is expected to prioritize funding for studies that validate the safety and efficacy of emerging plastic surgery techniques. In an era where "aesthetic" procedures often dominate public perception, Dr. Mehrara’s focus on the reconstruction of function—such as the treatment of lymphedema—serves to highlight the essential nature of plastic surgery in the broader medical spectrum.
2. Mentorship and Human Capital
A core tenet of the incoming administration is the support of early-career investigators. By increasing grants for residents and young surgeons, Dr. Mehrara hopes to prevent the "brain drain" that occurs when talented surgeons choose clinical practice over research. Ensuring that the pipeline of scientific discovery remains robust is essential for the long-term sustainability of the profession.
3. Global Accessibility and Equity
The PSF’s mission extends beyond the borders of the United States. Dr. Mehrara has signaled an interest in strengthening international partnerships to expand access to safe, effective, and affordable reconstructive care. This global focus is critical, as many regions lack the specialized surgical training required for complex reconstructive procedures. Through educational outreach and collaborative research, The PSF, under his guidance, intends to elevate standards of care worldwide.
4. Technological Integration
The rise of artificial intelligence, robotic surgery, and regenerative medicine represents a new frontier. Dr. Mehrara’s history of leading high-tech research labs suggests that The PSF will likely increase its investment in these areas. Whether through funding novel regenerative scaffolds or exploring the use of AI in predicting surgical outcomes, the foundation is poised to become a central hub for technological adoption in surgery.
Conclusion: A Legacy in the Making
As Dr. Mehrara begins his tenure, the medical community is watching with high expectations. The challenges facing plastic surgery—ranging from regulatory hurdles in new procedures to the increasing demand for high-quality, outcome-focused care—require a leader who can balance the rigor of a scientist with the empathy of a clinician.
Dr. Mehrara possesses a unique vantage point. Having spent his career at the pinnacle of oncologic reconstruction at Memorial Sloan Kettering, he understands the gravity of the stakes. When a patient undergoes reconstruction after cancer, the goal is not just appearance; it is the restoration of dignity and function. By carrying this philosophy into the presidency of The Plastic Surgery Foundation, Dr. Mehrara is set to leave a lasting impact on the field, ensuring that the next generation of plastic surgeons is equipped with the tools, the data, and the vision to transform lives.
The 12-month window of his presidency will undoubtedly be a period of intense activity for The PSF. Whether through the launch of new research initiatives or the solidification of global educational networks, Dr. Mehrara’s tenure promises to be defined by a commitment to the "legacy of excellence" he so frequently champions. As he navigates the complexities of modern medicine, his leadership stands as a beacon for what is possible when curiosity, skill, and a commitment to service converge at the highest levels of surgery.
About the Author
